Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Eksigent Technologies (Liquid Chromatography Business)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of liquid chromatography instruments and medical devices intended to separate, identify and quantify each component in a chemical mixture. The company's liquid chromatography devices include NanoLC-Ultra System for proteomics, the cHiPLC-nanoflex System for protein peptide separations and the ExpressHT-Ultra HPLC System for studies of pharmacokinetics and drug metabolism, enabling medical sector in the process of drugs development.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Chemicals and Gases
Acquirer
SCIEX
Primary Office
  • 6693 Sierra Lane
  • Suite A
  • Dublin, CA 94568
  • United States

Eksigent Technologies (Liquid Chromatography Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Eksigent Technologies (Liquid Chromatography Business)‘s full profile, request access.

Request full access to PitchBook

Eksigent Technologies (Liquid Chromatography Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Eksigent Technologies (Liquid Chromatography Business)‘s full profile, request access.

Request full access to PitchBook